Authors
Loading...
International registry reports improved survival outcomes from allo-HCT in patients with BPDCN, indicating risks and responses to treatments like venetoclax and chemotherapy.
Badikyan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: